XML 14 R2.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2024
Dec. 31, 2023
Assets:    
Cash and due from banks $ 81,342 $ 81,626
Cash at Federal Reserve and other banks 125,216 17,075
Cash and cash equivalents 206,558 98,701
Investment securities:    
Marketable equity securities 2,595 2,634
Trading securities 2,789 0
Available for sale debt securities, at fair value (amortized cost of $2,184,452 and $2,384,325) 1,940,783 2,152,504
Held to maturity debt securities, at amortized cost, net of allowance for credit losses of $0 122,673 133,494
Restricted equity securities 17,250 17,250
Loans held for sale 474 458
Loans 6,742,526 6,794,470
Allowance for credit losses (123,517) (121,522)
Total loans, net 6,619,009 6,672,948
Premises and equipment, net 70,621 71,347
Cash value of life insurance 138,525 136,892
Accrued interest receivable 35,527 36,768
Goodwill 304,442 304,442
Other intangible assets, net 8,492 10,552
Operating leases, right-of-use 25,113 26,133
Other assets 246,548 245,966
Total assets 9,741,399 9,910,089
Deposits:    
Noninterest-bearing demand 2,557,063 2,722,689
Interest-bearing 5,493,167 5,111,349
Total deposits 8,050,230 7,834,038
Accrued interest payable 12,018 8,445
Operating lease liability 27,122 28,261
Other liabilities 128,063 145,982
Other borrowings 247,773 632,582
Junior subordinated debt 101,143 101,099
Total liabilities 8,566,349 8,750,407
Commitments and contingencies (Note 9)
Shareholders’ equity:    
Preferred stock, no par value: 1,000,000 shares authorized, zero issued and outstanding at June 30, 2024 and December 31, 2023 0 0
Common stock, no par value: 50,000,000 shares authorized; 32,989,327 and 33,268,102 issued and outstanding at June 30, 2024 and December 31, 2023, respectively 691,878 697,349
Retained earnings 644,687 615,502
Accumulated other comprehensive loss, net of tax (161,515) (153,169)
Total shareholders’ equity 1,175,050 1,159,682
Total liabilities and shareholders’ equity $ 9,741,399 $ 9,910,089